Cover Image
市場調查報告書

全球重點照護(POC)臨床化學·免疫診斷檢驗市場新境界:商務課題,新技術,競爭環境

2017 POC/Point-of-Care Clinical Chemistry and Immunodiagnostic Testing Market: New Frontiers, Business Challenges, Emerging Technologies, Competitive Landscape

出版商 Venture Planning Group 商品編碼 304985
出版日期 內容資訊 英文 500 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球重點照護(POC)臨床化學·免疫診斷檢驗市場新境界:商務課題,新技術,競爭環境 2017 POC/Point-of-Care Clinical Chemistry and Immunodiagnostic Testing Market: New Frontiers, Business Challenges, Emerging Technologies, Competitive Landscape
出版日期: 內容資訊: 英文 500 Pages
簡介

本報告提供全球主要國家(美國·德國·西班牙)的重點照護(POC)臨床化學·免疫診斷檢驗相關的市場現狀·未來展望分析,提供相關技術及市場(檢驗試劑·試劑等)的最新情形,及各國·各部門的市場規模及成長率(今後5年份),法規環境,競爭結構,今後的需求·技術活用方法的方向性,及主要企業簡介等調查。

簡介

摘要整理

臨床化學·免疫診斷檢驗(全30種)

內分泌功能檢驗(全13種)

治療藥物監測檢驗(TDM)(全11種)

免疫蛋白質審定(全2種)

藥物濫用(全12種)

化學·免疫疾病檢驗用分析設備(全15公司份)

現在·未來的技術

  • 單株抗體
  • 流行病學的審定
  • 乾式化學分析
  • 生物感應器
  • IT·自動化
  • 分子診斷

美國市場

  • 市場概況
    • 商務環境
    • 市場結構
  • 開業醫生·聯合診療
  • 輔助的醫療設備
  • 癌症診所
  • 門診病人治療中心
  • 外科手術中心
  • 看護設備
  • 產院
  • 主要供應商的銷售額·市場佔有率

德國市場

  • 商務環境
  • 市場結構
  • 市場概況
  • 檢查數量·銷售額預測
  • 主要供應商的銷售額·市場佔有率

西班牙市場

  • 商務環境
  • 市場結構
  • 市場概況
  • 檢查數量·銷售額預測
  • 主要供應商的銷售額·市場佔有率

主要產品的開發機會

  • 例行性·特殊化學檢驗
  • 微生物/傳染病檢查
  • 血液檢驗·流式細胞技術
  • 血液凝固檢查

分散式檢查產品的設計標準

替代性的市場普及策略

  • 內部開發
  • 合資企業協定
  • 與大學的契約
  • 分散式檢查市場流通策略
    • 行銷的方法
    • 產品的複雜性
    • 客戶的偏好
    • 既有廠商
    • 新加入廠商
    • 主要種類的流通業者
    • 市場分類

加入市場的潛在障礙與風險

  • 市場的成熟度
  • 成本控制
  • 競爭
  • 技術的限制
  • 專利保護
  • 法規的限制
  • 分散檢驗市場課題

競爭企業簡介

  • Abbott Laboratories
  • AdnaGen
  • Agilent Technologies
  • Beckman Coulter/Danaher
  • Biomedical Diagnostics
  • BioMerieux
  • Bio-Rad
  • DiaSorin
  • 榮研化學
  • FUJIREBIO/Innogenetics
  • Grifols
  • Instrumentation Laboratory
  • 協和MEDEX株式會社
  • Matritech/Alere
  • Ortho-Clinical Diagnostics
  • Quest Diagnostics
  • Roche
  • Siemens
  • Sysmex
  • Thermo Fisher
  • Tosoh
  • 和光純藥工業
  • Wallac/PE

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: VPPOC23499

VPGMarketResearch’s new report provides comprehensive analysis of the POC clinical chemistry markets, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers.

Rationale

The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.

Market Segmentation

- Review of the POC clinical chemistry and immunodiagnostic market segments, including their dynamics, trends, structure, size, growth and major suppliers.

- Five-year test volume and reagent sales forecasts clinical chemistry procedures by market segment:
Physician Offices/Group Practices Emergency Rooms Operating/Recovery Suites ICUs/CCUs Cancer Clinics Ambulatory Care Centers Surgery Centers Nursing Homes Birth Centers

Sales and Market Share Analysis

- Sales and market shares of major reagent and instrument suppliers.

Routine Clinical Chemistry Tests

Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, AST/SGOT, Bilirubin, Blood Gases, BUN (Blood Urea Nitrogen), Calcium, Cholesterol, Cholinesterase, Creatinine, CK-MB, Electrolytes (Carbon Dioxide/Bicarbonate, Chloride, Potassium, Sodium), Ferritin, Follate/Folic Acid, Fructosamine,   GGT, Glucose, HDL, Iron, LDH, Magnesium, Phosphorus, Potassium, Protein, Sodium, Triglycerides, Troponin, Uric Acid, Urinalysis, Vitamin B12.

Endocrine Function Tests

Cortisol, Estradiol, FSH, HCG, Gastrin, LH, Progesterone, PTH/IO PTH, Prolactin, T3, T3 Uptake, Free T3, T4, Free T4, TBG, Testosterone, TSH.

Therapeutic Drug Monitoring (TDM) Tests

Amikacin, Carbamazepine, Digoxin, Gentamicin, Lidocaine, Lithium, Methotrexate, Phenobarbital, Phenytoin/Dilatin, NAPA/Procainamide, Quinidine, Theophylline, Tobramycin, Valproic Acid, Vancomycin.

Immunoprotein Tests

C3, C4, CRP, IgA, IgE Specific, IgE Total, IgG, Immunoglobulins, Protein Electrophoresis, and others.

Drugs of Abuse

Amphetamines, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine, Propoxyphene, and others.

Technology Review

- Emerging technologies and their applications for POC testing.

- Comprehensive listings of companies developing or marketing POC diagnostic technologies, and products, by test.

Strategic Recommendations

- Specific opportunities for new POC instruments and reagent systems with potentially significant market appeal during the next five years.

- Design criteria for POC testing products.

- Alternative business expansion strategies.

- Potential market entry barriers and risks.

Competitive Assessments

- Assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, joint ventures, and new products in R&D.

- The companies analyzed in the report include:

   - Abbott    - Accriva    - ADI/American Diagnostica    - Agilent Technologies    - Alere/Biosite/Inverness    - Axis-Shield    - Beckman Coulter/Danaher    - Becton Dickinson    - Bio/Data    - Biomerieux    - Bio-Rad    - Cepheid    - Chrono-Log    - Corgenix    - Decode Genetics    - Diadexus    - Diagnocure    - Diagnostica Stago/Trinity Biotech    - Diamedix/Erba    - Diasorin    - Eiken Chemical    - EKF Diagnostics    - Fujirebio    - Grifols    - Helena Laboratories    - Hologic/Gen-Probe    - Horiba    - Instrumentation Laboratory    - Kreatech/Leica    - Kyowa Medex    - Lonza    - Mackay Life Sciences    - Matritech    - Nihon Kohden    - Ortho-Clinical Diagnostics    - Polartechnics    - Polymedco    - Qiagen    - Roche    - SDIX    - Sequenom    - Siemens    - Sienco    - Sysmex    - Takara Bio    - Thermo Fisher    - Tosoh    - Wako    - Zycare/Alere

Methodology

This report is based on a combination of primary and secondary sources of information, including review of recent technical and business publications, manufacturer product literature, industry analyst reports, and VPGMarketResearch's proprietary data files.

Contains 500 pages and 129 tables

Table of Contents

Introduction

Executive Summary

Rationale for Testing Decentralization

  • 1. Overview
  • 2. Regulatory Trends
  • 3. Economic Trends
  • 4. Demographic Trends
  • 5. Technological Trends
  • 6. Social Trends
  • 7. Quality of Care
  • 8. Defensive Medicine
  • 9. Quality Control Issues

Review of Clinical Chemistry Immunodiagnostic Tests

  • 1. Albumin
  • 2. Alkaline Phosphatase
  • 3. ALT/SGPT
  • 4. Ammonia
  • 5. Amylase
  • 6. AST/SGOT
  • 7. Bilirubin
  • 8. Blood Gases
  • 9. Blood Urea Nitrogen (BUN)
  • 10. Calcium
  • 11. Cholesterol
  • 12. Cholinesterase
  • 13. Creatinine
  • 14. Electrolytes
    • a. Carbon Dioxide/Bicarbonate
    • b. Chloride
    • c. Potassium
    • d. Sodium
  • 15. Ferritin
  • 16. Follate/Folic Acid
  • 17. Fructosamine
  • 18. Gamma-Glutamyl Transpeptidase (GGT)
  • 19. Glucose
  • 20. High Density Lipoprotein (HDL)
  • 21. Iron
  • 22. Lactate Dehydrogenase (LDH)
  • 23. Magnesium
  • 24. Phosphorus
  • 25. Protein
  • 26. Triglycerides
  • 27. Troponin
  • 28. Uric Acid
  • 29. Urinalysis
  • 30. Vitamin B12

Endocrine Function Tests

  • 1. Cortisol
  • 2. Follicle-Stimulating Hormone (FSH)
  • 3. Gastrin
  • 4. Human Chorionic Gonadotropin (HCG)
  • 5. LH
  • 6. Prolactin
  • 7. T3
  • 8. T3 Uptake
  • 9. Free T3
  • 10. Thyroxine (T4)
  • 11. Free T4
  • 12. TBG
  • 13. TSH

Therapeutic Drug Monitoring (TDM)

  • 1. Overview
  • 2. Carbamazepine
  • 3. Digoxin
  • 4. Gentamicin
  • 5. Lidocaine
  • 6. Lithium
  • 7. Phenytoin/Dilantin
  • 8. Procainamide
  • 9. Quinidine
  • 10. Theophylline
  • 11. Valproic Acid

Immunoprotein Tests

  • 1. CRP
  • 2. Immunoglobulins

Drugs of Abuse

  • 1. Overview
  • 2. Test Methodologies
  • 3. Amphetamines
  • 4. Barbiturates
  • 5. Benzodiazepines
  • 6. Cannabinoids/Marijuana
  • 7. Cocaine
  • 8. Lysergic Acid Diethylamide (LSD)
  • 9. Methadone
  • 10. Methaqualone
  • 11. Opiates
  • 12. Phencyclidine

Instrumentation: Chemistry Immunodiagnostic Analyzers Manufactured by:

  • Abaxis
  • Abbott
  • Alfa Wassermann
  • Awareness Technologies
  • Beckman Coulter/Danaher
  • bioMeriuex
  • Carolina Chemistries
  • Horiba
  • Inverness
  • Medica
  • Nova Biomedical
  • Ortho-Clinical Diagnostics
  • Polimedco
  • Randox
  • Roche

Current and Emerging Technologies

  • 1. Monoclonal Antibodies
  • 2. Immunoassays
    • a. Technological Principle
    • b. Enzyme Immunoassays (EIA)
      • Overview
      • ELISA
      • Dot Immunobinding Assays
      • Capillary Immunoassays
      • Particle-Membrane Capture Immunoassay
      • Enzyme Amplification
    • c. Fluorescent Immunoassays
      • Fluorescent Polarization
      • Time-Resolved Pulse Fluorescence
    • d. Luminescence
      • Chemiluminescence
      • Bioluminescence
    • e. Latex Agglutination
    • f. Immunoprecipitation
  • 3. Dry Chemistry
  • 4. Biosensors
  • 5. IT and Automation
  • 6. Molecular Diagnostics
    • a. Technology Overview
    • b. Amplification Methods
      • Polymerase Chain Reaction
      • Ligase Chain Reaction
      • Branched DNA
      • Q-Beta Replicase
      • Strand Displacement Activation
      • Self-Sustained Sequence Replicase

U.S.A.

A. Market Overview

  • 1. Business Environment
    • a. Health Care Expenditures
    • b. Cost Consciousness
    • c. Reimbursement
    • d. Industry Consolidation
    • e. Managed Care
      • PPO
      • HMO
    • f. Hospitals
    • g. Admissions
    • h. Length of Stay
    • i. Industry Diversification
    • j. Physician Demographics
    • k. Aging Population
      • More Chronic Illness
      • Disease Incidence
      • Susceptibility to latrogenesis
      • Multiple Illnesses Cases
    • l. Laboratory Regulations
  • 2. Market Structure
    • a. Hospitals
    • b. Commercial/Private Laboratories

B. Physician Offices/Group Practices

  • 1. Market Summary
  • 2. Market Structure
  • 3. Test Volume and Sales Forecasts

C. Ancillary Hospital Locations

  • 1. Introduction
    • a. Emergency Departments
    • b. Operating Suites
    • c. Intensive Care Units
  • 2. Emergency Departments
    • a. Market Summary
    • b. Test volume and Sales Forecasts
  • 3. Operating and Recovery Suites
    • a. Market Summary
    • b. Test Volume and Sales Forecasts
  • 4. ICUs/CCUs
    • a. Market Summary
    • b. Test Volume and Sales Forecasts

D. Cancer Clinics

  • 1. Introduction
  • 2. Market Summary
  • 3. Test Volume and Sales Forecasts

E. Ambulatory Care Centers

  • 1. Introduction
  • 2. Market Summary
  • 3. Market Structure
  • 4. Test Volume and Sales Forecasts

F. Surgery Centers

  • 1. Introduction
  • 2. Market Summary
  • 3. Market Structure
  • 4. Test Volume and Sales Forecasts

G. Nursing Homes

  • 1. Introduction
  • 2. Market Summary
  • 3. Market Structure
  • 4. Test Volume and Sales Forecasts

H. Birth Centers

  • 1. Introduction
  • 2. Market Summary
  • 3. Market Structure
  • 4. Test Volume and Sales Forecasts

I. Major Suppliers' Sales and Market Shares

Germany

  • A. Market Overview
  • B. Market Structure
  • C. Market Summary
  • D. Test Volume and Sales Forecasts
  • E. Major Suppliers' Sales and Market Shares

Spain

  • A. Business Environment
  • B. Market Structure
  • C. Market Summary
  • D. Test Volume and Sales Forecasts
  • E. Major Suppliers' Sales and Market Shares

Major Product Development Opportunities

  • A. Routine and Special Chemistry
  • B. Microbiology/Infectious Diseases
  • C. Hematology and Flow Cytometry
  • D. Coagulation

Design Criteria for Decentralized Testing Products

Alternative Market Penetration Strategies

  • A. Internal Development
  • B. Collaborative Arrangements
  • C. University Contracts
  • D. Distribution Strategies for Decentralized Testing Markets
    • 1. Marketing Approaches
    • 2. Product complexity
    • 3. Customer Preference
    • 4. Established Suppliers
    • 5. Emerging Suppliers
    • 6. Major Types of Distributors
    • 7. Market Segmentation

Potential Market Entry Barriers and Risks

  • A. Market Maturity
  • B. Cost Containment
  • C. Competition
  • D. Technological Edge and Limitations
  • E. Patent Protection
  • F. Regulatory Constraints
  • G. Decentralized Testing Market Challenges

Company Profile

  • Abbott Laboratories
  • AdnaGen
  • Agilent Technologies
  • Beckman Coulter/Danaher
  • Biomedical Diagnostics
  • BioMerieux
  • Bio-Rad
  • DiaSorin
  • Eiken
  • Fujirebio/Innogenetics
  • Grifols
  • Instrumentation Laboratory
  • Kyowa Medex
  • Matritech/Alere
  • Ortho-Clinical Diagnostics
  • Quest Diagnostics
  • Roche
  • Siemens
  • Sysmex
  • Thermo Fisher
  • Tosoh
  • Wako
  • Wallac/PE

List of Tables

  • Major Companies Developing or Marketing Albumin Tests
  • Major Companies Developing or Marketing Alkaline Phosphatase Tests
  • Major Companies Developing or Marketing ALT/SGPT Tests
  • Major Companies Developing or Marketing Amylase Tests
  • Major Companies Developing or Marketing AST/SGOT Tests
  • Major Companies Developing or Marketing Bilirubin Tests
  • Major Companies Developing or Marketing Blood Gas Analyzers
  • Major Companies Developing or Marketing BUN Tests
  • Major Companies Developing or Marketing Calcium Tests
  • Major Companies Developing or Marketing Cholesterol Tests
  • Major Companies Developing or Marketing Creatinine Tests
  • Major Companies Developing or Marketing Electrolyte Tests
  • Major Companies Developing or Marketing Ferritin Tests
  • Major Companies Developing or Marketing GGT Tests
  • Major Companies Developing or Marketing Glucose Tests
  • Major Companies Developing or Marketing HDL Tests
  • Major Companies Developing or Marketing Iron Tests
  • Major Companies Developing or Marketing LDH Tests
  • Major Companies Developing or Marketing Magnesium Tests
  • Major Companies Developing or Marketing Phosphorus Tests
  • Major Companies Developing or Marketing Protein Tests
  • Major Companies Developing or Marketing Triglycerides Tests
  • Major Companies Developing or Marketing Uric Acid Tests
  • Major Companies Developing or Marketing Vitamin B-12/Folate Tests
  • Major Companies Developing or Marketing FSH Tests
  • Major Companies Developing or Marketing HCG Tests
  • Major Companies Developing or Marketing LH Tests
  • Major Companies Developing or Marketing Prolactin Tests
  • Major Companies Developing or Marketing T3 Tests
  • Major Companies Developing or Marketing T4 Tests
  • Major Companies Developing or Marketing TSH Tests
  • Major Companies Developing or Marketing TDM Tests
  • Major Companies Developing or Marketing Digoxin Tests
  • Major Companies Developing or Marketing Lithium Tests
  • Major Companies Developing or Marketing Phenytoin/Dilantin Tests
  • Major Companies Developing or Marketing Theophylline Tests
  • Major Companies Developing or Marketing Valproic Acid Tests
  • Major Companies Developing or Marketing Drugs of Abuse Tests
  • U.S.A., Office-Based Physicians Forecast by Practice Type
  • U.S.A., Physician Offices/Group Practices Forecast by Type
  • U.S.A., Physician Office/Group Practice Laboratories Forecast by Practice Size
  • U.S.A., Physician Offices/Group Practices Routine and Special Chemistry Test Volume Forecast
  • U.S.A., Physician Offices/Group Practices TDM Test Volume Forecast
  • U.S.A., Physician Offices/Group Practices Endocrine Function Test Volume Forecast
  • U.S.A., Physician Offices/Group Practices Major Tumor Marker Test Volume Forecast
  • U.S.A., Physician Offices/Group Practices Immunoprotien Test Volume Forecast
  • U.S.A., Physician Offices/Group Practices Drugs of Abuse Test Volume Forecast
  • U.S.A., Physician Offices/Group Practices Routine and Special Chemistry Test Volume Forecast by Practice Type
  • U.S.A., Physician Offices/Group Practices TDM Test Volume Forecast by Practice Type
  • U.S.A., Physician Offices/Group Practices Endocrine Function Test Volume Forecast by Practice Type
  • U.S.A., Physician Offices/Group Practices Tumor Markers Test Volume Forecast by Practice Type
  • U.S.A., Physician Offices/Group Practices Immunoprotein Test Volume Forecast by Practice Type
  • U.S.A., Physician Offices/Group Practices Drugs of Abuse Test Volume Forecast by Practice Type
  • U.S.A., Physician Offices/Group Practices Routine and Special Chemistry Reagent Market Forecast by Test
  • U.S.A., Physician Offices/Group Practices TDM Reagent Market Forecast by Test
  • U.S.A., Physician Offices/Group Practices Endocrine Function Reagent Market Forecast by Test
  • U.S.A., Physician Offices/Group Practices Major Tumor Marker Reagent Market Forecast by Test
  • U.S.A., Physician Offices/Group Practices Immunoprotein Reagent Market Forecast by Test
  • U.S.A., Physician Offices/Group Practices Drugs of Abuse Reagent Market Forecast by Test
  • U.S.A., Ancillary Hospital Locations Estimated Number
  • U.S.A., Ancillary Hospital Locations Annual Utilization
  • U.S.A., Hospital Emergency Departments Routine and Special Chemistry Test Volume Forecast
  • U.S.A., Hospital Emergency Departments Profiles, Panels and Individual Tests
  • U.S.A., Hospital Emergency Departments Drugs of Abuse Test Volume Forecast
  • U.S.A., Hospital Emergency Departments Routine and Special Chemistry Reagent Market Forecast by Test
  • U.S.A., Hospital Emergency Departments Drugs of Abuse Reagent Market Forecast by Test
  • U.S.A., Hospital Operating and Recovery Suites Routine and Special Chemistry Reagent Test Volume Forecast
  • U.S.A., Hospital Operating and Recovery Suites Routine and Special Chemistry Reagent Market Forecast by Test
  • U.S.A., Hospital ICUs/CCUs Total Diagnostics Sales Forecast by Market Segment
  • U.S.A., Hospital ICUs/CCUs Reagent Sales Forecast by Market Segment
  • U.S.A., Hospital ICUs/CCUs Instrument Sales Forecast by Market Segment
  • U.S.A., Hospital ICUs/CCUs Routine and Special Chemistry Test Volume Forecast
  • U.S.A., Hospital ICUs/CCUs Routine and Special Chemistry Reagent Market Forecast by Test
  • U.S.A., Cancer Clinics Routine And Special Chemistry Test Volume Forecast
  • U.S.A., Cancer Clinics Endocrine Function Test Volume Forecast
  • U.S.A., Cancer Clinics Routine and Special Chemistry Reagent Market Forecast by Test
  • U.S.A., Cancer Clinics Endocrine Function Reagent Market Forecast
  • U.S.A., Ambulatory Care Centers Estimated Number of Facilities and Patient Visits
  • U.S.A., Ambulatory Care Centers Most Frequent Diagnoses
  • U.S.A., Ambulatory Care Centers Routine and Special Chemistry Test Volume Forecast
  • U.S.A., Ambulatory Care Centers Drugs of Abuse Test Volume Forecast
  • U.S.A., Ambulatory Care Centers Routine and Special Chemistry Reagent Market Forecast by Test
  • U.S.A., Ambulatory Care Centers Drugs of Abuse Reagent Market Forecast by Test
  • U.S.A., Surgery Centers Most Frequently Performed Procedures
  • U.S.A., Surgery Centers Routine and Special Chemistry Test Volume Forecast
  • U.S.A., Surgery Centers Routine and Special Chemistry Reagent Market Forecast by Test
  • U.S.A., Nursing Homes Estimated Number of Facilities, Beds and Occupancy Rate
  • U.S.A., Nursing Homes Routine and Special Chemistry Test Volume Forecast
  • U.S.A., Nursing Homes Routine and Special Chemistry Reagent Market Forecast by Test
  • U.S.A., Birth Centers Facilities, Patient Visits, and Births
  • U.S.A., Birth Centers Routine and Special Chemistry Test Volume Forecast
  • U.S.A., Birth Centers Profiles, Panels and Individual Tests
  • U.S.A., Birth Centers Routine and Special Chemistry Reagent Market Forecast by Test
  • U.S.A., Major Suppliers of Clinical Chemistry Diagnostics Products, Estimated Sales and Market Shares
  • U.S.A., Major Suppliers of Clinical Chemistry Reagents, Estimated Market Shares
  • U.S.A., Major Suppliers of Clinical Chemistry Analyzers, Estimated Market Shares
  • U.S.A., Major Suppliers of Immunodiagnostic Products, Estimated Market Shares
  • U.S.A., Major Suppliers of Immunoassay Reagents, Estimated Market Shares
  • U.S.A., Major Suppliers of Immunoassay Analyzers, Estimated Market Shares
  • Germany, Physician Offices/Group Practices Routine and Special Chemistry Test Volume Forecast
  • Germany, Physician Offices/Group Practices Endocrine Function Test Volume Forecast
  • Germany, Physician Offices/Group Practices Major Cancer Diagnostic Test Volume Forecast
  • Germany, Physician Offices/Group Practices Immunoprotein Test Volume Forecast
  • Germany, Physician Offices/Group Practices TDM Test Volume Forecast
  • Germany, Physician Offices/Group Practices Routine Chemistry Reagent Market Forecast
  • Germany, Physician Offices/Group Practices Cancer Diagnostics Market Forecast by Test
  • Germany, Physician Offices/Group Practices Endocrine Function Diagnostics Market Forecast
  • Germany, Physician Offices/Group Practices TDM Reagent Market Forecast
  • Germany, Physician Offices/Group Practices Immunoprotein Reagent Market Forecast
  • Germany, Physician Offices/Group Practices Drugs of Abuse Reagent Market Forecast
  • Germany, Major Suppliers of Clinical Chemistry Diagnostic Products Estimated Market Shares
  • Germany, Major Suppliers of Clinical Chemistry Reagent Estimated Market Shares
  • Germany, Major Suppliers of Clinical Chemistry Analyzers Estimated Market Shares
  • Germany, Major Suppliers of Immunodiagnostic Products Estimated Market Shares
  • Germany, Major Suppliers of Immunodiagnostic Reagent Estimated Market Shares
  • Germany, Major Suppliers of Immunoassay Analyzers Estimated Market Shares
  • Spain, Laboratory Performing Chemistry and Immunoassay Tests Forecast by Market Segment
  • Spain, Ambulatory Care Centers Routine and Special Chemistry Test Volume Forecast
  • Spain, Ambulatory Care Centers Endocrine Function Test Volume Forecast
  • Spain, Ambulatory Care Centers TDM Test Volume Forecast
  • Spain, Ambulatory Care Centers Immunoprotein Test Volume Forecast
  • Spain, Ambulatory Care Centers Drugs of Abuse Test Volume Forecast
  • Spain, Ambulatory Care Centers Routine and Special Chemistry Reagent Market Forecast
  • Spain, Ambulatory Care Centers Endocrine Function Reagent Market Forecast
  • Spain, Ambulatory Care Centers TDM Reagent Market Forecast
  • Spain, Ambulatory Care Centers Immunoprotein Reagent Market Forecast
  • Spain, Ambulatory Care Centers Drugs of Abuse Reagent Market Forecast
  • Spain, Major Suppliers of Clinical Chemistry Diagnostic Products Estimated Market Shares
  • Spain, Major Suppliers of Immunodiagnostics Products Estimated Market Shares
Back to Top